Help employers make wellbeing spend more measurable.
Corporate wellness testing is most useful when it gives employees practical health context and gives programme owners a more serious alternative to participation-only perks. MeScreen can sit alongside wellbeing, benefits or executive-health initiatives where the aim is prevention, recovery and resilience rather than medical diagnosis.
The MeScreen mitochondrial function test is priced at £599 and combines at-home sample collection with reporting across cellular-energy and biomarker themes. For employers, the value is not a promise to “fix burnout”; it is a more evidence-aware way to help staff understand personal health signals and seek appropriate follow-up when needed.
Reports are intended to support informed wellness conversations, not to diagnose workplace stress or medical conditions.
A corporate programme needs consent, privacy and careful language.
MeScreen is best framed as an optional wellness benefit for employees who want deeper insight into energy, recovery and preventive health markers.
Employees should be able to choose whether to take part, understand what is being tested, and know how results will be delivered before a kit is ordered.
Individual results should remain personal to the employee. Employers should only use aggregated, non-identifying themes if a programme is designed to review team-level trends.
New symptoms, abnormal clinical concerns, urgent changes in health or medication questions should be directed to a GP, NHS 111, urgent care or emergency services as appropriate.
Use MeScreen where wellness needs better evidence.
MeScreen can support senior leadership wellbeing, high-performance teams, return-to-wellness initiatives, benefit pilots and prevention-focused staff offers. It is particularly relevant when a programme already discusses fatigue, recovery, metabolic health or resilience, but needs a more substantial route than generic advice.
- Premium benefit for employees who want more personal health context.
- At-home sampling that avoids adding clinic logistics to a workplace programme.
- Report-led follow-up that can sit beside coaching, nutrition, GP or private clinician support.
- UK-localised communications that avoid overstating claims or implying diagnosis.
Do not use testing as a shortcut for workplace risk management.
Work-related stress, fatigue and burnout concerns should be handled through proper workplace health, safety and management processes. The Health and Safety Executive expects employers to assess and manage work-related stress risks; a private wellness test is not a substitute for that duty.
MeScreen should be positioned as supportive personal insight. It should not be used to screen employees for capability, make employment decisions, monitor productivity or replace occupational-health assessment.
Keep rollout simple and medically cautious.
Reviewed for mitochondrial-context accuracy.
MeScreen references Dr Hemal Patel’s mitochondrial biology expertise to keep workplace-facing content careful and grounded.
Last updated: 16 May 2026 for UK corporate wellness and clinical-boundary guidance.
Corporate wellness testing FAQ
What is corporate wellness testing?
Corporate wellness testing uses structured health data to support prevention-focused staff wellbeing programmes. MeScreen adds mitochondrial function and mitochondrial function reporting while keeping diagnosis and treatment decisions with qualified clinicians.
How could a UK employer use MeScreen responsibly?
A UK employer can offer MeScreen as an optional wellness benefit, explain the limits clearly, protect individual privacy, and use only aggregated non-identifying themes for programme planning where appropriate.
Does MeScreen diagnose burnout, fatigue or medical conditions?
No. MeScreen is a wellness and functional laboratory assessment. It does not diagnose burnout, fatigue syndromes, metabolic disease or any medical condition, and it does not replace NHS or private medical care.
What should HR teams tell employees before rollout?
Employees should know what the test measures, how sample collection works, the expected reporting route, the cost or funding model, and when to speak with a GP or urgent care service instead.
What is the next step for a corporate wellness department?
The next step is to speak with MeScreen about team size, eligibility, communications, privacy boundaries and whether the mitochondrial function test is suitable for the planned wellbeing programme.
Speak to MeScreen before you position testing to staff.
A short conversation can clarify team size, eligibility, privacy boundaries, employee communications and the most appropriate route into MeScreen.